Illusio

Regulation Crowdfunding offering on Equifund

$227,210

of $1.07M goal

21.2% funded

About the offering

A Breakthrough That Could Become Standard In Every Cosmetic Surgical Office Worldwide. This cutting edge tool allows patients to visualize intimate details of very personal surgical decisions. It’s a breakthrough that could be quickly adopted as “best practice” for every plastic surgical office worldwide. Mentor Worldwide is deploying their national sales team to take the lead in introducing this company’s groundbreaking technology to the medical community. Before it gains traction, you may want to consider grabbing a position. The company is ILLUSIO. Its unique, proprietary visualization technology could revolutionize how doctors and patients interact over the most intimate details of plastic surgical procedures. Plastic surgeons report that the most frustrating aspect of their practice can be managing the expectations of their patients and assisting them in visualizing outcomes of procedures that each must accept and approve before surgery. ILLUSIO technology simplifies the process and clarifies results. It allows the patient to see the range of cosmetic options available to approve in advance of the procedure. Using state-of-the-art augmented reality (AR) and newly developed AR interfaces, ILLUSIO enables doctors to present to patients real-time, three-dimensional visualizations of body shaping procedures with detailed accuracy. Patients see on screen, on their own bodies, the range of results that can be expected from any procedure.

FAQ

How much has Illusio raised?

Illusio has raised $227,210 of a $1.07M goal.

Where is Illusio's campaign listed?

The offering is listed on Equifund, an SEC-registered Reg CF intermediary.

What are the terms of Illusio's raise?

Common Stock, $15M cap, $1.09/share.

When does Illusio's offering close?

The stated close date is Apr 30, 2020.